Altamira Therapeutics Ltd. (NASDAQ:CYTO) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Altamira Therapeutics First Half 2024 and Business Update Conference Call.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Armistice Capital Steven Boyd | 101,444 | $61,901 | 0% | |
2. | Citadel Investment Group Ken Griffin | 14,802 | $9,353 | 0% |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 6,814 | $23,713 | 0% | |
2. | 851 | $2,961 | 0% | |
3. | 14 | $49 | 0% | |
4. | 1 | $3 | 0% | |
5. | 0 | $0 | 0% |